Light Mode
$1.33 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.33, $0.12 below the day’s high of $1.44
-0.07 (-5.36%) / 6M
Momentum, market sentiment, and recent alerts
PMVP reads not so good: price sits above one of the two key moving averages, the 12-month move is -1.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.